← FDA DRUG APPROVALS

FDA NDA · NDA012285

SYNTOCINON

Sponsor: RTRX

APPLICATION
NDA012285
TYPE
NDA
ROUTE
NASAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

SYNTOCINONDiscontinued
OXYTOCIN 40USP UNITS/ML · SOLUTION · NASAL
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →